Everything below concerns MC1R. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-04-10. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
| Molecular weight | Approximately 1024 g/mol | Calculated for the free base |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and polar solvents | Poorly soluble in non-polar solvents |
| Typical storage | -20 degrees Celsius, dry, protected from light | Refers to the solid form |
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
Unwanted side effects cause people to stop treatment, resulting in relapses. Antipsychotics can have the side effect of extrapyramidal symptoms. Extrapyramidal symptoms are movement disorders that include dystonia, akathisia, parkinsonism, tremor, and tardive dyskinesia. Risperidone (atypical) has a similar rate of extrapyramidal symptoms to haloperidol (typical). A rare but potentially lethal condition of neuroleptic malignant syndrome (NMS) has been associated with the use of antipsychotics. Through its early recognition, and timely intervention rates have declined. However, an awareness of the syndrome is advised to enable intervention. Very rarely antipsychotics may cause tardive psychosis. Generally, more than one antipsychotic drug should not be used at a time because of increased adverse effects.
ALD is caused by mutations in ABCD1, located at Xq28 and demonstrates X-linked recessive inheritance. The gene ABCD1 encodes a peroxisomal membrane transporter which is responsible for transporting very long chain fatty acid substrate into the peroxisomes for degradation. Mutations in this gene that interfere with this process cause this syndrome. Males with an ABCD1 mutation are hemizygous, as they only have a single X chromosome. Female carriers will typically avoid the most severe manifestations of the disease, but often become symptomatic later in life. Although the detection of an ABCD1 mutation identifies an individual who is affected with a form of ALD, there is no genotype–phenotype correlation. Within a family, there will often be several different phenotypes, despite the presence of the same causative mutation. In one case, a family with six affected members displayed five different phenotypes. There are no common mutations that cause ALD, most are private or familial. Almost 600 different mutations have been identified, approximately half are missense mutations, one quarter are frameshifts, with in-frame deletions and splicing defects making up the remainder. The incidence of new mutations in ALD (those occurring spontaneously, rather than being inherited from a carrier parent) is estimated at 4.1%, with the possibility that these are due to germline mosaicism.
Chemical engineering – Engineering discipline focused on the design and operation of chemical plants Chemical reactor – Enclosed volume where interconversion of compounds takes place Medical science liaison – Connecting biotechnology and health care Pharmaceutical formulation – Process for producing a final medicinal product Pharmaceutical packaging – Packaging for pharmaceutical preparationsPages displaying short descriptions of redirect targets Site Master File – Synthesis of pharmaceutical drugsPages displaying short descriptions of redirect targets 3D drug printing – 3D printing of customized medicationPages displaying short descriptions of redirect targets
Acetyl-CoA carboxylase 1 (ACC1) Carbamoyl phosphate synthetase 1 (CPS1) Carnitine palmitoyltransferase 1 (CPT1) Enolase 1 (ENO1) Formyltetrahydrofolate dehydrogenase, 10- (ALDH1L1) Fructose bisphosphate aldolase B (ALDOB) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Histone H2B Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) Very long-chain acyl-CoA dehydrogenase (VLCAD)
Sources: en.wikipedia.org
In October 2003, the People's Republic of China commenced its first crewed spaceflight, Shenzhou 5. The astronaut, Yang Liwei, brought along with him and ate specially processed yuxiang pork (Chinese: 鱼香肉丝), Kung Pao chicken (Chinese: 宫保鸡丁), and Eight Treasures rice (Chinese: 八宝饭), along with Chinese herbal tea. Food made for this flight and the subsequent crewed flight in 2007 has been commercialized for sale to the mass market. At Tiangong space station, meals consisting of 120 different types of food, selected based on astronauts' preferences, are stored aboard. Staples including shredded pork in garlic sauce, kung pao chicken, black pepper beef, yuxiang shredded pork, pickled cabbage, and beverages, including a variety of teas and juices, are resupplied by trips of the Tianzhou-class robotic cargo spacecraft. Fresh fruits and vegetables are stored in coolers. Huang Weifen, the chief astronaut trainer of CMSA, explains that most of the food is prepared to be solid, boneless, and in small pieces. Condiments such as pork sauce and Sichuan pepper sauce are used to compensate for the changes in the sense of taste in microgravity. Food items are often adjusted according to astronauts' feedback, such as when larger supplies of vegetables were included in Tianzhou 4. Additionally, China's Tiangong-2 station has conducted experiments growing food on board in a micro-gravity environment, such as thale cress, a form of edible weed, as well as rice.
Thus, when the neuron is at a depolarized membrane potential, polyamines will block the AMPAR channel more strongly, preventing the flux of potassium ions through the channel pore. GluA2-lacking AMPARs are, thus, said to have an inwardly rectifying I/V curve, which means that they pass less outward current than inward current at equivalent distance from the reversal potential. Calcium permeable AMPARs are found typically early during postnatal development on neocortical pyramidal neurons, some interneurons, or in dopamine neurons of the ventral tegmental area after the exposure to an addictive drug. Alongside RNA editing, alternative splicing allows a range of functional AMPA receptor subunits beyond what is encoded in the genome. In other words, although one gene (GRIA1–GRIA4) is encoded for each subunit (GluA1–GluA4), splicing after transcription from DNA allows some exons to be translated interchangeably, leading to several functionally different subunits from each gene. The flip/flop sequence is one such interchangeable exon. A 38-amino acid sequence found prior to (i.e., before the N-terminus of) the fourth membranous domain in all four AMPAR subunits, it determines the speed of desensitization of the receptor and also the speed at which the receptor is resensitized and the rate of channel closing. The flip form is present in prenatal AMPA receptors and gives a sustained current in response to glutamate activation.
Violence remained most consistent and most severe in the Vaal and surrounds, but by the end of 1985 it had affected most of the country's townships. In early 1985, the unrest spread across the Witwatersrand, across the Orange Free State, and across the eastern part of the Cape Province (the hub of the country's automotive industry). By August 1985, it had entered the western part of the Cape, the eastern Transvaal, and parts of Natal.
Little People of the World Organization Archived 2021-05-10 at the Wayback Machine [Hub for all International Organizations; services/advocacy/know your rights/support] Little People of America (Includes a list of International support groups) Little People of Canada (Includes a list of Canadian Provincial support groups) Little People UK Dwarf Sports Association UK Restricted Growth Association UK
High-resolution Nuclear Magnetic Resonance. McGraw-Hill Book Company. John D. Roberts (1959). Nuclear Magnetic Resonance: applications to organic chemistry. McGraw-Hill Book Company. ISBN 978-1-258-81166-2. {{cite book}}: ISBN / Date incompatibility (help) Charles P. Slichter (1963). Principles of magnetic resonance: with examples from solid state physics. Harper & Row. ISBN 978-3-540-08476-1. {{cite book}}: ISBN / Date incompatibility (help) J.M. Tyszka; S.E. Fraser; R.E. Jacobs (2005). "Magnetic resonance microscopy: recent advances and applications". Current Opinion in Biotechnology. 16 (1): 93–99. doi:10.1016/j.copbio.2004.11.004. PMID 15722021. Kurt Wüthrich (1986). NMR of Proteins and Nucleic Acids. New York (NY), US: Wiley-Interscience. ISBN 978-0-471-11917-3.
Sources: en.wikipedia.org
Laserspray inlet ionization (LSII) is a subset of MAII and uses a matrix-assisted laser desorption/ionization (MALDI) method. It was originally called atmospheric pressure matrix-assisted laser desorption/ionization however was renamed as LSII to avoid confusion with MALDI and as it was found to be a type of inlet ionization. As all inlet ionization techniques, highly multiply charged ions are produced. A nitrogen laser is used to ablate the solid matrix/analyte into the heated inlet tube, the observed ions are generated at the surface of the matrix/analyte and so the laser is not directly involved in the ionization as was originally thought. LSII can determine protein molecular weights and has been found to detect masses of proteins up to 20,000 Da. The sensitivity of LSII, for protein detection, is higher by an order of magnitude compared to ESI.
As they flee, Neo suddenly discovers that he can now sense the sentinels and shuts them down telepathically; however, the effort causes him to fall unconscious. He and the crew are rescued by the hovercraft Mjolnir (also known as the Hammer) whose crew is dealing with a mystery in the form of Bane, a crew member from another ship who is the only survivor of an ill-fated attack by the Zion fleet. Unbeknownst to anyone, Bane's mind was destroyed by Smith at some point during the movie's events during which Smith overwrote himself over Bane's avatar, effectively killing Bane and once he was unplugged, taking over Bane's real body.
There is limited evidence that moisturizing soap bar; combinations of water soak, oil soak, and lotion are effective in maintaining the skin integrity of elderly people when compared to standard care.
== Clinical significance == A tumor of the delta cells is called a "somatostatinoma". When a person is infected with H. pylori the lower region of the stomach, the antrum, is predominantly inflamed. This is where most of the δ-cells in the stomach are. The bacteria produce a cloud of ammonia around themselves using urease to protect them from the stomach acid; however, this reacts with the acid producing ammonium which is toxic to cells. This leads to many of the δ-cells dying, an effect that is further compounded by the low PD-L1 expression on the δ-cells as compared to gastric G cells (resulting in higher susceptibility of δ-cells to inflammatory responses). In turn, this results in a lower level of somatostatin being secreted and consequently higher release of gastrin and stomach acid. This, combined with the damage from ammonium, leads to ulceration of the stomach wall.
Sources: en.wikipedia.org
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.
Both are synthetic analogues derived from the same parent hormone. Reference descriptions usually characterise afamelanotide as more selective for the MC1R subtype, whereas melanotan-2 is reported to interact with a wider range of melanocortin receptors.
Early studies explored melanocortin signalling and pigmentation, which later led to informal use of the label tanning peptide. That label is not a regulatory category and does not imply approved status for any purpose.
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.